| 摘要 |
A method for the treatment of a disease or condition associated with increased numbers of neutrophils and/or neutrophil over-activation in a mammal such as a human, which method comprises administering an effective, non-toxic and pharmaceutically acceptable amount of a PPARgamma agonist, such as Compound (I), to a mammal in need thereof.
|
